Krka Posts Double-Digit Profit, Sales Growth
Novo Mesto, 24 January - Pharmaceutical company Krka saw profits surge 53% to SIT 21.6bn (EUR 90.16m) in 2005 on sales of SIT 116.8bn (EUR 487.52), up 19% year-on-year, the company's preliminary, unaudited results suggest.
The rest of this news item is available to subscribers.
The news item consists of 1.107 characters (without spaces) or 214 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.